SNCA
Seneca Biopharma Inc
Halal Rating :
Last Price
$1.48
Last updated:
Market Cap
-
7D Change
-19.13%
1 Year Change
179.25%
Company Overview
Exchange
Next Earnings Date
Palisade Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics that protect the integrity of the intestinal barrier. Their lead product candidate, LB1148, is being developed to accelerate the return of bowel function following surgery and reduce certain postoperative complications.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Seneca Biopharma Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.